Amicus Therapeutics Stock Forecast - Simple Exponential Smoothing

FOLD Stock  USD 10.82  0.21  1.98%   
The Simple Exponential Smoothing forecasted value of Amicus Therapeutics on the next trading day is expected to be 10.82 with a mean absolute deviation of  0.24  and the sum of the absolute errors of 14.46. Amicus Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Amicus Therapeutics stock prices and determine the direction of Amicus Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Amicus Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Amicus Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Amicus Therapeutics' systematic risk associated with finding meaningful patterns of Amicus Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Amicus Therapeutics to cross-verify your projections.
For information on how to trade Amicus Stock refer to our How to Trade Amicus Stock guide.
  
At present, Amicus Therapeutics' Payables Turnover is projected to increase slightly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 7.23, whereas Receivables Turnover is forecasted to decline to 3.54. . The current year's Common Stock Shares Outstanding is expected to grow to about 309.9 M, whereas Net Loss is forecasted to decline to (223.6 M).

Open Interest Against 2024-05-17 Amicus Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Amicus Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Amicus Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Amicus Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Amicus Therapeutics' open interest, investors have to compare it to Amicus Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Amicus Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Amicus. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Amicus Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Amicus Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Amicus Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Amicus Therapeutics simple exponential smoothing forecast is a very popular model used to produce a smoothed price series. Whereas in simple Moving Average models the past observations for Amicus Therapeutics are weighted equally, Exponential Smoothing assigns exponentially decreasing weights as Amicus Therapeutics prices get older.

Amicus Therapeutics Simple Exponential Smoothing Price Forecast For the 24th of April

Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Amicus Therapeutics on the next trading day is expected to be 10.82 with a mean absolute deviation of 0.24, mean absolute percentage error of 0.11, and the sum of the absolute errors of 14.46.
Please note that although there have been many attempts to predict Amicus Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Amicus Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Amicus Therapeutics Stock Forecast Pattern

Backtest Amicus TherapeuticsAmicus Therapeutics Price PredictionBuy or Sell Advice 

Amicus Therapeutics Forecasted Value

In the context of forecasting Amicus Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Amicus Therapeutics' downside and upside margins for the forecasting period are 8.28 and 13.36, respectively. We have considered Amicus Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
10.82
10.82
Expected Value
13.36
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Amicus Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Amicus Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria114.022
BiasArithmetic mean of the errors 0.0253
MADMean absolute deviation0.241
MAPEMean absolute percentage error0.0195
SAESum of the absolute errors14.46
This simple exponential smoothing model begins by setting Amicus Therapeutics forecast for the second period equal to the observation of the first period. In other words, recent Amicus Therapeutics observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Amicus Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Amicus Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Amicus Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
8.3510.8713.39
Details
Intrinsic
Valuation
LowRealHigh
10.1012.6215.14
Details
11 Analysts
Consensus
LowTargetHigh
15.7717.3319.24
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.1-0.07-0.03
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Amicus Therapeutics. Your research has to be compared to or analyzed against Amicus Therapeutics' peers to derive any actionable benefits. When done correctly, Amicus Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Amicus Therapeutics.

Other Forecasting Options for Amicus Therapeutics

For every potential investor in Amicus, whether a beginner or expert, Amicus Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Amicus Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Amicus. Basic forecasting techniques help filter out the noise by identifying Amicus Therapeutics' price trends.

View Amicus Therapeutics Related Equities

 Risk & Return  Correlation

Amicus Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Amicus Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Amicus Therapeutics' current price.

Amicus Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Amicus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Amicus Therapeutics shares will generate the highest return on investment. By undertsting and applying Amicus Therapeutics stock market strength indicators, traders can identify Amicus Therapeutics entry and exit signals to maximize returns.

Amicus Therapeutics Risk Indicators

The analysis of Amicus Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Amicus Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting amicus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Amicus Therapeutics is a strong investment it is important to analyze Amicus Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amicus Therapeutics' future performance. For an informed investment choice regarding Amicus Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Amicus Therapeutics to cross-verify your projections.
For information on how to trade Amicus Stock refer to our How to Trade Amicus Stock guide.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Complementary Tools for Amicus Stock analysis

When running Amicus Therapeutics' price analysis, check to measure Amicus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amicus Therapeutics is operating at the current time. Most of Amicus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Amicus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amicus Therapeutics' price. Additionally, you may evaluate how the addition of Amicus Therapeutics to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Is Amicus Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amicus Therapeutics. If investors know Amicus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amicus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.51)
Revenue Per Share
1.353
Quarterly Revenue Growth
0.306
Return On Assets
(0.06)
Return On Equity
(1.07)
The market value of Amicus Therapeutics is measured differently than its book value, which is the value of Amicus that is recorded on the company's balance sheet. Investors also form their own opinion of Amicus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Amicus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amicus Therapeutics' market value can be influenced by many factors that don't directly affect Amicus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amicus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amicus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amicus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.